GUIDED THERAPEUTICS, INC. Deferred Revenue
GUIDED THERAPEUTICS, INC. (GTHP) had Deferred Revenue of $189.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-13
- 2026-06-30: Deferred Revenue, Current $189.00K.
- 2026-03-31: Deferred Revenue, Current $189.00K.
- 2025-12-31: Deferred Revenue, Current $189.00K.
- 2025-09-30: Deferred Revenue, Current $689.00K.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2026-06-30 | $189.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $189.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $189.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $689.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $679.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $670.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $849.00K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $748.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $748.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $748.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $424.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $451.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $445.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $488.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $509.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $509.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $513.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $514.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $337.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $278.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $62.00K 10-Q · filed 2021-08-18 | |
| 2021-03-31 | $62.00K 10-Q/A · filed 2021-08-18 | |
| 2020-12-31 | $42.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $42.00K 10-Q/A · filed 2020-11-05 | |
| 2020-06-30 | $101.00K 10-Q · filed 2020-08-20 | |
| 2020-03-31 | $101.00K 10-Q · filed 2020-07-07 | |
| 2019-12-31 | $101.00K 10-K · filed 2021-04-07 | $66.00K 10-Q · filed 2020-03-09 |
| 2019-09-30 | $98.00K 10-Q · filed 2020-03-09 |